399 related articles for article (PubMed ID: 26806063)
1. Clinical and Angiographic Features of Patients with Moyamoya Disease and the p.R4810K Heterozygous Variant.
Zhang Q; Zhang D; Wang R; Liu Y; Zhang Y; Wang S; Zhao J
World Neurosurg; 2016 Jun; 90():530-538.e3. PubMed ID: 26806063
[TBL] [Abstract][Full Text] [Related]
2. Importance of RNF213 polymorphism on clinical features and long-term outcome in moyamoya disease.
Kim EH; Yum MS; Ra YS; Park JB; Ahn JS; Kim GH; Goo HW; Ko TS; Yoo HW
J Neurosurg; 2016 May; 124(5):1221-7. PubMed ID: 26430847
[TBL] [Abstract][Full Text] [Related]
3. Genotype-Phenotype Correlation in Long-Term Cohort of Japanese Patients with Moyamoya Disease.
Nomura S; Yamaguchi K; Akagawa H; Kawashima A; Moteki Y; Ishikawa T; Aihara Y; Saito T; Okada Y; Kawamata T
Cerebrovasc Dis; 2019; 47(3-4):105-111. PubMed ID: 30947170
[TBL] [Abstract][Full Text] [Related]
4. The Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease and a Review of the Pertinent Literature.
Zhang Q; Liu Y; Yu L; Duan R; Ma Y; Ge P; Zhang D; Zhang Y; Wang R; Wang S; Zhao Y; Cao Y; Liu X; Deng X; Zhao J; Zhang X
World Neurosurg; 2017 Mar; 99():701-708.e1. PubMed ID: 28063898
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Genetic Risk Factors of Long-Term Outcomes after Encephaloduroarteriosynangiosis in Moyamoya Disease in China.
Wang X; Zhang Z; Wang Y; Zou Z; Ta N; Hao F; Shang M; Li D; Zeng F; Han C; Nie F; Bao X; Yang Y; Wang H; Liang M; Yang R; Ou L; Wen L; Yang Z; Liu W; Duan L
J Stroke Cerebrovasc Dis; 2021 Jul; 30(7):105847. PubMed ID: 33992965
[TBL] [Abstract][Full Text] [Related]
6. Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.
Liao X; Deng J; Dai W; Zhang T; Yan J
Environ Health Prev Med; 2017 Nov; 22(1):75. PubMed ID: 29165161
[TBL] [Abstract][Full Text] [Related]
7. Association between p.R4810K Variant and Postoperative Collateral Formation in Patients with Moyamoya Disease.
Ge P; Ye X; Liu X; Deng X; Wang J; Wang R; Zhang Y; Zhang D; Zhang Q; Zhao J
Cerebrovasc Dis; 2019; 48(1-2):77-84. PubMed ID: 31578010
[TBL] [Abstract][Full Text] [Related]
8. Development of atherosclerotic-moyamoya syndrome with genetic variant of RNF213 p.R4810K and p.T1727M: A case report.
Liu Y; Wu X; Fan Z; Cheng J; Zhong L; Lin Y; Qu X
Clin Neurol Neurosurg; 2018 May; 168():163-166. PubMed ID: 29567577
[TBL] [Abstract][Full Text] [Related]
9. Absence of the RNF213 p.R4810K variant may indicate a severe form of pediatric moyamoya disease in Japanese patients.
Hara S; Mukawa M; Akagawa H; Thamamongood T; Inaji M; Tanaka Y; Maehara T; Kasuya H; Nariai T
J Neurosurg Pediatr; 2022 Jan; 29(1):48-56. PubMed ID: 34624841
[TBL] [Abstract][Full Text] [Related]
10. Significant Association of the RNF213 p.R4810K Polymorphism with Quasi-Moyamoya Disease.
Morimoto T; Mineharu Y; Kobayashi H; Harada KH; Funaki T; Takagi Y; Sakai N; Miyamoto S; Koizumi A
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2632-2636. PubMed ID: 27476341
[TBL] [Abstract][Full Text] [Related]
11. Predictive role of heterozygous p.R4810K of
Wang Y; Zhang Z; Wei L; Zhang Q; Zou Z; Yang L; Li D; Shang M; Han C; Mambiya M; Bao X; Li Q; Hao F; Zhang K; Wang H; Liu S; Liu M; Zeng F; Nie F; Wang K; Liu W; Duan L
Neurology; 2020 Feb; 94(7):e678-e686. PubMed ID: 31949090
[TBL] [Abstract][Full Text] [Related]
12. RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance.
Zhang Q; Liu Y; Zhang D; Wang R; Zhang Y; Wang S; Yu L; Lu C; Liu F; Zhou J; Zhang X; Zhao J
J Neurosurg; 2017 Apr; 126(4):1106-1113. PubMed ID: 27128593
[TBL] [Abstract][Full Text] [Related]
13. Ethnic variation and the relevance of homozygous RNF 213 p.R4810.K variant in the phenotype of Indian Moya moya disease.
K A; Shafeeque CM; Sudhir JB; Banerjee M; P N S
PLoS One; 2020; 15(12):e0243925. PubMed ID: 33370357
[TBL] [Abstract][Full Text] [Related]
14. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.
Cao Y; Kobayashi H; Morimoto T; Kabata R; Harada KH; Koizumi A
Environ Health Prev Med; 2016 Sep; 21(5):387-390. PubMed ID: 27365075
[TBL] [Abstract][Full Text] [Related]
15. Angiographic characteristics in Moyamoya disease with the p.R4810K variant: a propensity score-matched analysis.
Ge P; Zhang Q; Ye X; Liu X; Deng X; Wang J; Wang R; Zhang Y; Zhang D; Zhao J
Eur J Neurol; 2020 May; 27(5):856-863. PubMed ID: 32073714
[TBL] [Abstract][Full Text] [Related]
16. Renovascular hypertension and
Kim JY; Cho H
Clin Nephrol; 2021 Aug; 96(2):105-111. PubMed ID: 33769276
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.
Wu Z; Jiang H; Zhang L; Xu X; Zhang X; Kang Z; Song D; Zhang J; Guan M; Gu Y
PLoS One; 2012; 7(10):e48179. PubMed ID: 23110205
[TBL] [Abstract][Full Text] [Related]
18. RNF213 p.R4810K Variant and Intracranial Arterial Stenosis or Occlusion in Relatives of Patients with Moyamoya Disease.
Matsuda Y; Mineharu Y; Kimura M; Takagi Y; Kobayashi H; Hitomi T; Harada KH; Uchihashi Y; Funaki T; Miyamoto S; Koizumi A
J Stroke Cerebrovasc Dis; 2017 Aug; 26(8):1841-1847. PubMed ID: 28506590
[TBL] [Abstract][Full Text] [Related]
19. Validation and Extension Study Exploring the Role of RNF213 p.R4810K in 2,877 Chinese Moyamoya Disease Patients.
Wang Y; Zhang Z; Wang X; Zou Z; Ta N; Hao F; Yang Y; Li D; Liang M; Han C; Bao X; Ou L; Wang H; Yang Z; Yang R; Zeng F; Shang M; Nie F; Liu W; Duan L
J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106071. PubMed ID: 34482123
[TBL] [Abstract][Full Text] [Related]
20. Role of the
Kim HJ; Choi EH; Chung JW; Kim JH; Kim YS; Seo WK; Kim GM; Bang OY
J Am Heart Assoc; 2021 Jan; 10(1):e017660. PubMed ID: 33356381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]